Chinese Pharma Recovers Most Of Contaminated Human Rabies Vaccine
This article was originally published in PharmAsia News
China's Dalian Jingang-Andi Bio-products says it has recovered nearly all of the 360,200 doses of its human rabies vaccine, 20 percent of the Chinese market, found to be contaminated. The company produced the vaccine last year, but tests in January by the General Administration of Quality Supervision, Inspection and Quarantine, found an illegal nucleic acid adjuvant. The agency had announced earlier that nucleic acid materials could not be used in human vaccines until they undergo clinical trials. No deaths from the vaccine have been reported, a company spokeswoman said. (Click here for more
You may also be interested in...
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.